<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="gcps" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">gcps</book-part-id>
      <title-group>
        <title>Greig Cephalopolysyndactyly Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Cephalopolysyndactyly Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Biesecker</surname>
            <given-names>Leslie G</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Medical Genomics and Metabolic Genetics Branch <break/>National Human Genome Research Institute<break/>National Institutes of Health <break/>Bethesda, Maryland</aff>
          <email>lesb@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2001-07-09" date-type="created">
          <day>9</day>
          <month>7</month>
          <year>2001</year>
        </date>
        <date iso-8601-date="2014-06-19" date-type="updated">
          <day>19</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2006-08-14" date-type="revised">
          <day>14</day>
          <month>8</month>
          <year>2006</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gsd6" document-type="chapter">Glycogen Storage Disease Type VI</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hemochromatosis" document-type="chapter">
<italic toggle="yes">HFE</italic>-Associated Hereditary Hemochromatosis</related-object>
      <abstract id="gcps.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by preaxial polydactyly or mixed pre- and postaxial polydactyly, true widely spaced eyes, and macrocephaly. Individuals with mild GCPS may have subtle craniofacial findings. The mild end of the GCPS spectrum is a continuum with preaxial polysyndactyly type IV and crossed polydactyly (preaxial polydactyly of the feet and postaxial polydactyly of the hands plus syndactyly of fingers 3-4 and toes 1-3). Individuals with severe GCPS can have seizures, hydrocephalus, and intellectual disability.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of GCPS is based on clinical findings and family history. <italic toggle="yes">GLI3</italic> is the only gene known to be associated with GCPS; <italic toggle="yes">GLI3</italic> alterations (i.e., cytogenetic abnormalities involving <italic toggle="yes">GLI3</italic> or pathogenic variants of <italic toggle="yes">GLI3</italic>) can be identified in more than 75% of typically affected individuals.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Elective surgical repair of polydactyly with greatest priority given to correction of preaxial polydactyly of the hands; evaluation and treatment as needed for hydrocephalus or other CNS abnormalities in individuals showing signs of increased intracranial pressure, developmental delay, loss of milestones, and/or seizures.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitoring for evidence of occipitofrontal circumference (OFC) increasing faster than normal.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>GCPS either is inherited in an autosomal dominant manner (either as a pathogenic variant in <italic toggle="yes">GLI3</italic> or as a deletion of 7p13 involving <italic toggle="yes">GLI3</italic>) or occurs as the result of a <italic toggle="yes">de novo</italic> or inherited chromosome rearrangement. Individuals with GCPS as the result of a <italic toggle="yes">GLI3</italic> pathogenic variant may have an affected parent or may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown. Each child of an individual with a <italic toggle="yes">GLI3</italic> pathogenic variant has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the underlying genetic cause in the family (i.e., deletion of 7p13, balanced chromosome rearrangement, or <italic toggle="yes">GLI3</italic> pathogenic variant) has been identified. The reliability of ultrasound examination for prenatal diagnosis is unknown.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="gcps.Diagnosis">
        <title>Diagnosis</title>
        <p>Major findings of Greig cephalopolysyndactyly syndrome (GCPS) are the following.</p>
        <p><bold>Macrocephaly.</bold> Occipitofrontal (head) circumference (OFC) is greater than 97th centile compared to appropriate age- and sex-matched normal standards [<xref ref-type="bibr" rid="gcps.REF.allanson.2009.6">Allanson et al 2009</xref>]. Note: An enlarged OFC must be interpreted with caution in families in which a parent (or parents) of the proband has benign familial macrocephaly (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/153470">OMIM</ext-link>).</p>
        <p>Some individuals with GCPS have a high anterior hairline, and a prominent (or bossed) forehead.</p>
        <p><bold>Widely spaced eyes.</bold> Interpupillary distance is more than 2 SD above the mean (newborns 27-41 weeks&#x02019; gestational age or interpupillary distance above the 97th centile (age 0-15 years) or a subjectively increased interpupillary distance [<xref ref-type="bibr" rid="gcps.REF.hall.2009.29">Hall et al 2009</xref>]. Increased inner canthal distance (i.e., telecanthus, or apparent widely spaced eyes) may be present as well but is not as distinctive a finding as increased interpupillary distance. Increased interpupillary distance is often associated with a wide nasal bridge.</p>
        <p>
          <bold>Limb anomalies</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Preaxial polydactyly.</bold> At least one limb should manifest one of the following [<xref ref-type="bibr" rid="gcps.REF.biesecker.2009.93">Biesecker et al 2009</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>Preaxial polydactyly (duplication of all or part of the first ray)</p>
              </list-item>
              <list-item>
                <p>A markedly broad hallux (visible increase in width of the hallux without an increase in the dorso-ventral dimension)</p>
              </list-item>
              <list-item>
                <p>A markedly broad thumb (increased thumb width without increased dorso-ventral dimension)</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Other limbs may manifest preaxial or postaxial polydactyly and some limbs may have five normal digits. The postaxial polydactyly may be type A, type B, or intermediate forms.</p>
            <list list-type="bullet">
              <list-item>
                <p>Postaxial polydactyly type A (PAP-A) is the presence of a well-formed digit on the ulnar or fibular aspect of the limb.</p>
              </list-item>
              <list-item>
                <p>Postaxial polydactyly type B (PAP-B) is the presence of a rudimentary digit or nubbin in the same location. The finding of postaxial polydactyly type B must be evaluated critically when present in an individual of west-central African descent as that feature is a common variant (1% prevalence).</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Some individuals have widening of the first digit apparent only on x-ray. This is difficult to assess when diagnosing a proband.</p>
          </list-item>
          <list-item>
            <p><bold>Cutaneous syndactyly.</bold> The cutaneous syndactyly may be partial or complete; in occasional severe cases, parts of the distal phalanges may be fused.</p>
          </list-item>
        </list>
        <sec id="gcps.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>A <bold>presumptive diagnosis</bold>* is established in a proband with preaxial polydactyly, cutaneous syndactyly of toes 1-3 or fingers 3-4, widely spaced eyes, and macrocephaly.</p>
          <p>Note: The diagnosis should be made with caution in infants with multiple other malformations, especially in the absence of a positive family history.</p>
          <p>A <bold>firm diagnosis</bold>* is established in:</p>
          <list list-type="bullet">
            <list-item>
              <p>A first-degree relative of a proband for whom the diagnosis has been independently established. The first-degree relative of a proband may be diagnosed as affected if he/she has pre- or postaxial polydactyly with or without syndactyly or the craniofacial features. Note: Postaxial polydactyly type B should not be used as a diagnostic criterion for first-degree relatives of persons who are of west-central African descent.</p>
            </list-item>
            <list-item>
              <p>A proband who has features of GCPS and a pathogenic variant in <italic toggle="yes">GLI3.</italic></p>
            </list-item>
          </list>
          <p>*The distinction of <bold>presumptive</bold> and <bold>firm diagnoses</bold> is based on data of <xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al [2005]</xref>, who suggested that the clinical criteria were useful but may not be sufficiently specific to warrant a "firm" diagnosis on clinical grounds alone. A small but significant fraction of individuals with features of GCPS do not have a pathogenic variant in <italic toggle="yes">GLI3</italic>. This, coupled with the fact that the features of GCPS may be a component of many other syndromes, warrants caution in applying these diagnostic criteria.</p>
        </sec>
        <sec id="gcps.Testing">
          <title>Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">GLI3</italic> is the only gene in which pathogenic variants are known to be associated with Greig cephalopolysyndactyly syndrome.</p>
          <table-wrap id="gcps.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Greig Cephalopolysyndactyly Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">GLI3</italic>
                  </td>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70%&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4,&#x000a0;5,&#x000a0;6</sup></td>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5%-10%&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Loss of heterozygosity analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_gcps.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~50%-75%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="gcps.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="gcps" object-id="gcps.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="gcps.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="gcps.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="gcps.TF.1.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al [2005]</xref>
                </p>
              </fn>
              <fn id="gcps.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="gcps.TF.1.5">
                <label>5. </label>
                <p>To date, every person with a deletion or duplication of <italic toggle="yes">GLI3</italic> has had a different breakpoint and the sizes of the deletions have ranged from one exon to more than 10 Mb [<xref ref-type="bibr" rid="gcps.REF.johnston.2007.e59">Johnston et al 2007</xref>]. Because <italic toggle="yes">GLI3</italic> is about 300 kb in size, large deletions may not necessarily alter the signal of any given <italic toggle="yes">GLI3</italic> FISH, array CGH, or MLPA probe. Therefore, no single testing modality can detect all such deletions and translocations, making it difficult to quote a detection rate for any single testing modality.</p>
              </fn>
              <fn id="gcps.TF.1.6">
                <label>6. </label>
                <p>Giemsa-banded karyotypes do not detect all deletions, even those on the order of 1 Mb [unpublished observations].</p>
              </fn>
              <fn id="gcps.TF.1.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="gcps.REF.johnston.2003.236">Johnston et al [2003]</xref>
                </p>
              </fn>
              <fn id="gcps.TF.1.8">
                <label>8. </label>
                <p>Detects <italic toggle="yes">GLI3</italic> deletions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="gcps.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirmation of the diagnosis in a proband.</bold> Two salient clinical features should be considered prior to diagnostic testing. The first is the presence of developmental delay or intellectual disability in the proband. The second is a history of recurrent pregnancy losses in the parents of the proband.</p>
          <list list-type="bullet">
            <list-item>
              <p>For individuals with clinical features consistent with GCPS, and without significant developmental delay or intellectual disability or pregnancy losses in the parents, sequence analysis of <italic toggle="yes">GLI3</italic> should be considered first, followed by CGH analysis if no <italic toggle="yes">GLI3</italic> pathogenic variant is identified, followed by Giemsa-banded karyotyping if no <italic toggle="yes">GLI3</italic> pathogenic variant has been identified by the other two methods.</p>
            </list-item>
            <list-item>
              <p>If the patient has significant developmental delay or intellectual disability, CGH analysis should be done first, followed by sequence analysis of <italic toggle="yes">GLI3</italic>, and then Giemsa-banded karyotyping if no <italic toggle="yes">GLI3</italic> pathogenic variant has been identified by the other two methods.</p>
            </list-item>
            <list-item>
              <p>If there is a family history of parental pregnancy losses, a Giemsa-banded karyotype should be considered first, followed by sequence analysis of <italic toggle="yes">GLI3</italic> and then CGH.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="gcps.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="gcps.Clinical_Description">
          <title>Clinical Description</title>
          <p>Several large families have been reported as having a mild form of GCPS with excellent general health and normal longevity.</p>
          <p>Developmental delay, intellectual disability, or seizures appear to be uncommon manifestations (estimated at &#x0003c;10%) of GCPS. These complications are more likely if the child has CNS malformations (rare) or hydrocephalus (uncommon), and they may be more common in individuals with large (&#x0003e;300 kb) deletions that encompass <italic toggle="yes">GLI3</italic> [<xref ref-type="bibr" rid="gcps.REF.johnston.2007.e59">Johnston et al 2007</xref>].</p>
        </sec>
        <sec id="gcps.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Individuals who have GCPS associated with a large (&#x0003e;300 kbp) deletion have a more severe phenotype than those with chromosome translocations or single nucleotide variants in <italic toggle="yes">GLI3</italic> [<xref ref-type="bibr" rid="gcps.REF.kroisel.2001.243">Kroisel et al 2001</xref>, <xref ref-type="bibr" rid="gcps.REF.johnston.2007.e59">Johnston et al 2007</xref>]. Individuals with large deletions appear to have a higher incidence of intellectual disability, seizures, and CNS anomalies. This phenomenon is presumably caused by haploinsufficiency of multiple genes in the vicinity of <italic toggle="yes">GLI3</italic>.</p>
          <p>Two individuals with a severe GCPS phenotype that overlaps with acrocallosal syndrome (see <xref ref-type="fig" rid="gcps.F1">Figure 1</xref>) have been found to have a pathogenic missense variant in <italic toggle="yes">GLI3</italic> [<xref ref-type="bibr" rid="gcps.REF.elson.2002.804">Elson et al 2002</xref>, <xref ref-type="bibr" rid="gcps.REF.speksnijder.2013.1394">Speksnijder et al 2013</xref>].</p>
          <p>A genotype-phenotype correlation has been demonstrated on two levels:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Class of variant.</bold> Pathogenic variants of all classes can cause GCPS whereas the only class of pathogenic variants that causes the allelic disorder <related-object link-type="booklink" source-id="gene" document-id="phs" document-type="chapter">Pallister-Hall syndrome</related-object> is frameshifting variants. Haploinsufficiency for GLI3 causes GCPS, whereas truncating variants 3' of the zinc finger domain of <italic toggle="yes">GLI3</italic> generally cause PHS [<xref ref-type="bibr" rid="gcps.REF.kang.1997.266">Kang et al 1997</xref>] (<xref ref-type="fig" rid="gcps.F1">Figure 1A</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Variant position.</bold> Among all frameshift variants in <italic toggle="yes">GLI3</italic>, variants in the first third of the gene are only known to cause GCPS (<xref ref-type="fig" rid="gcps.F1">Figure 1B</xref>). Frameshifting variants in the middle third of the gene cause <related-object link-type="booklink" source-id="gene" document-id="phs" document-type="chapter">Pallister-Hall syndrome</related-object> and uncommonly cause GCPS. Frameshift variants in the final third of the gene cause GCPS. There is no apparent correlation of the variant position within each of the three regions and the severity of the respective phenotypes.</p>
            </list-item>
          </list>
        </sec>
        <sec id="gcps.Penetrance">
          <title>Penetrance</title>
          <p>One case of apparent non-penetrance has been reported [<xref ref-type="bibr" rid="gcps.REF.debeer.2003.49">Debeer et al 2003</xref>]. It is difficult to estimate a rate of non-penetrance from a single instance, but it is probably a small fraction.</p>
        </sec>
        <sec id="gcps.Anticipation">
          <title>Anticipation</title>
          <p>There is no evidence for genetic anticipation in GCPS.</p>
        </sec>
        <sec id="gcps.Nomenclature">
          <title>Nomenclature</title>
          <p>The term "Greig syndrome" describes the dyad of widely spaced eyes and macrocephaly. Because that dyad of anomalies is nonspecific, the term should not be used as a synonym for GCPS [<xref ref-type="bibr" rid="gcps.REF.gorlin.2001">Gorlin et al 2001</xref>].</p>
        </sec>
        <sec id="gcps.Prevalence">
          <title>Prevalence</title>
          <p>GCPS is rare and pan ethnic; the prevalence is unknown. Approximately 100 cases are known to this author. It is suspected that many individuals with preaxial polydactyly with syndactyly and mild craniofacial features are misdiagnosed as having isolated preaxial polydactyly instead of GCPS (see <xref ref-type="sec" rid="gcps.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>, <bold>PPDIV</bold>); however, the distinction may be semantic [<xref ref-type="bibr" rid="gcps.REF.biesecker.2008.10">Biesecker 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="gcps.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Other phenotypes known to be associated with pathogenic variants in <italic toggle="yes">GLI3</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="phs" document-type="chapter"><bold>Pallister-Hall syndrome</bold></related-object>
<bold>(PHS)</bold> comprises central or postaxial polydactyly, hypothalamic hamartoma, bifid epiglottis, imperforate anus or anal stenosis, and other anomalies. PHS displays a wide range of severity. There is confusion in the literature and it is often wrongly assumed that PHS is severe and Greig cephalopolysyndactyly syndrome is mild. A minority of individuals with PHS show multiple severe anomalies such as pituitary dysplasia with panhypopituitarism and laryngeal clefts or other airway anomalies, which may be life threatening in the neonatal period. However, most individuals with PHS are mildly affected with polydactyly and asymptomatic bifid epiglottis and hypothalamic hamartoma (HH).</p>
          </list-item>
          <list-item>
            <p><bold>Postaxial polydactyly type A (PAP-A)</bold> is not a syndrome but instead a limb malformation limited to the presence of a single, well-formed supernumerary postaxial digit on one or both hands and feet. There is some controversy regarding whether PAP-A is distinct from PHS or is instead a mild variant of PHS with mild, subtle, and asymptomatic bifid epiglottis, hypothalamic hamartoma, anal stenosis, and other signs.</p>
          </list-item>
          <list-item>
            <p><bold>Preaxial polydactyly type IV (PPD-IV)</bold> is essentially GCPS without craniofacial manifestations. Affected individuals typically have the same pattern of syndactyly in the hands and feet as individuals with GCPS.</p>
          </list-item>
          <list-item>
            <p><bold>Isolated preaxial polydactyly type IV (PPDIV)</bold> comprises preaxial polydactyly of the hands and/or feet in the absence of other malformations. The severity of the PPDIV is highly variable [<xref ref-type="bibr" rid="gcps.REF.everman.2006">Everman 2006</xref>]. Because macrocephaly occurs in the general population and is common in GCPS, the presence of macrocephaly in a person with apparently isolated PPDIV may be difficult to interpret.</p>
          </list-item>
        </list>
      </sec>
      <sec id="gcps.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Acrocallosal syndrome (ACLS) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/200990">OMIM</ext-link>) includes pre- or postaxial polydactyly, cutaneous syndactyly, agenesis of the corpus callosum (rare in GCPS), widely spaced eyes, macrocephaly, moderate to severe intellectual disability, intracerebral cysts, seizures, and umbilical and inguinal hernias. The disorder appears to be inherited in an autosomal recessive manner [<xref ref-type="bibr" rid="gcps.REF.koenig.2002.7">Koenig et al 2002</xref>] and can be caused by biallelic pathogenic variants in <italic toggle="yes">KIF7</italic> [<xref ref-type="bibr" rid="gcps.REF.putoux.2011.601">Putoux et al 2011</xref>]. The milder end of the ACLS phenotype can overlap with the severe end of the GCPS phenotype caused by interstitial deletions of 7p13 that delete <italic toggle="yes">GLI3</italic> and additional neighboring genes, as discussed in <xref ref-type="sec" rid="gcps.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
        <p>Some subtypes of oral-facial-digital syndrome have similar limb malformations [<xref ref-type="bibr" rid="gcps.REF.gorlin.2001">Gorlin et al 2001</xref>]. (See, for example, <related-object link-type="booklink" source-id="gene" document-id="ofd1" document-type="chapter">Oral-Facial-Digital Syndrome Type 1</related-object>.)</p>
        <p>Craniofrontonasal dysplasia has similar facial features [<xref ref-type="bibr" rid="gcps.REF.gorlin.2001">Gorlin et al 2001</xref>].</p>
      </sec>
      <sec id="gcps.Management">
        <title>Management</title>
        <sec id="gcps.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>Most individuals diagnosed with Greig cephalopolysyndactyly syndrome (GCPS) have the craniofacial and limb anomalies only. As for all individuals with malformations, a dysmorphology examination is appropriate to exclude other anomalies.</p>
          <p>Sophisticated imaging, especially of the CNS, is not routinely indicated unless the clinician detects findings or symptoms that specifically indicate such an evaluation.</p>
          <p>Similarly, as most individuals with GCPS have normal development, screening beyond the standard Denver Developmental Screening test is not recommended.</p>
        </sec>
        <sec id="gcps.Treatment_of_Manifestations">
          <title>Treatment of Manifestations *</title>
          <p>The author is not aware of craniofacial reconstructive surgery being performed on individuals with GCPS as the widely spaced eyes and macrocephaly are generally not sufficiently severe to warrant surgery.</p>
          <p>Repair of polydactyly should be undertaken on an elective basis. Preaxial polydactyly of the hands is considered to be a higher priority for surgical correction than postaxial polydactyly of the hand or any type of polydactyly of the foot because of the importance of early and proper development of the prehensile grasp.</p>
          <p>Cutaneous syndactyly of the fingers is usually repaired if it is more than minimal.</p>
          <p>As is true for any malformation of the feet, surgical correction must be carefully considered. Cosmetic benefits and easier fitting of shoes can be outweighed by potential orthopedic complications.</p>
          <p>Seizures are treated symptomatically.</p>
          <p>*As with the diagnostic criteria (see <xref ref-type="sec" rid="gcps.Diagnosis">Diagnosis</xref>), no published data support these recommendations, which are those of the author.</p>
        </sec>
        <sec id="gcps.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>The only recognized preventable secondary complication may be developmental delay, which may be preventable or ameliorated by early intervention.</p>
        </sec>
        <sec id="gcps.Surveillance">
          <title>Surveillance *</title>
          <p>Individuals with an OFC that is increasing faster than normal, signs of increased intracranial pressure, developmental delay, loss of milestones, or seizures should undergo appropriate CNS imaging studies to exclude hydrocephalus, other CNS abnormalities, or cerebral cavernous malformations (seen in some individuals with GCPS and large deletions [<xref ref-type="bibr" rid="gcps.REF.bilguvar.2007.495">Bilguvar et al 2007</xref>; Author, unpublished observations]).</p>
          <p>*As with the diagnostic criteria (see <xref ref-type="sec" rid="gcps.Diagnosis">Diagnosis</xref>), no published data support these recommendations, which are those of the author.</p>
        </sec>
        <sec id="gcps.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="gcps.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="gcps.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="gcps.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="gcps.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Greig cephalopolysyndactyly syndrome either is inherited in an autosomal dominant manner (as a pathogenic variant in <italic toggle="yes">GLI3</italic> or as a deletion of 7p13 involving <italic toggle="yes">GLI3</italic>) or occurs as the result of a <italic toggle="yes">de novo</italic> or inherited chromosome rearrangement.</p>
        </sec>
        <sec id="gcps.Risk_to_Family_Members__Autosomal_D">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with GCPS have an affected parent and some have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">GLI3</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a child with GCPS and no known family history of GCPS consist of clinical examination and x-rays of hands and feet unless physical signs suggest the need for other studies (e.g., neuroimaging for possible hydrocephalus in a parent). Molecular genetic testing of the parents is indicated if the <italic toggle="yes">GLI3</italic> pathogenic variant in the proband has been identified.</p>
            </list-item>
          </list>
          <p>Note: (1) Although some individuals diagnosed with GCPS have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members. (2) If the parent is the individual in whom the pathogenic variant first occurred s/he may have somatic mosaicism for the pathogenic variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the proband's parents:</p>
              <list list-type="bullet">
                <list-item>
                  <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
                </list-item>
                <list-item>
                  <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with GCPS has a 50% chance of inheriting the <italic toggle="yes">GLI3</italic> pathogenic variant. Since intrafamilial variability is generally low, affected offspring are expected to have clinical findings similar to those of the parent.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="gcps.Risk_to_Family_Members__Chromosome">
          <title>Risk to Family Members &#x02014; Chromosome Rearrangement</title>
          <p>Greig cephalopolysyndactyly syndrome can be the result of an inherited or <italic toggle="yes">de novo</italic> chromosome rearrangement.</p>
          <p><bold>Parents of a proband</bold>. Parents of a proband with an unbalanced structural chromosome constitution (e.g., deletion, duplication) are at risk of having a balanced chromosome rearrangement and should be offered chromosome analysis.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs of a proband with an unbalanced structural chromosome constitution depends on the chromosome findings in the parents.</p>
            </list-item>
            <list-item>
              <p>If neither parent has a structural chromosome rearrangement, the risk to sibs is negligible.</p>
            </list-item>
            <list-item>
              <p>If a parent has a balanced structural chromosome rearrangement, the risk to sibs is increased and depends on the specific chromosome rearrangement and the possibility of other variables.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Offspring of an individual with a balanced or unbalanced chromosome rearrangement are at risk of having a similar or related rearrangement.</p>
        </sec>
        <sec id="gcps.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>If a parent of the proband has a balanced chromosome rearrangement, at-risk family members can be tested by chromosome analysis.</p>
        </sec>
        <sec id="gcps.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Range of severity.</bold> A significant range of severity is associated with the GCPS designation; interfamilial variability is greater than intrafamilial variability: it is unlikely that a family with a mild GCPS phenotype will have a child affected with severe GCPS. This rule excludes founders who may theoretically be mildly affected because they have somatic mosaicism for a <italic toggle="yes">GLI3</italic> pathogenic variant. If a founder has germ cells with the pathogenic variant, his or her offspring may be affected; the affected offspring would be non-mosaic and thus could have a more severe phenotype than the parent.</p>
          <p>The prognosis for an individual who has no known family history of GCPS should be based on the malformations present in that individual. Literature surveys are not useful for this purpose because reported cases tend to show bias of ascertainment to more severe involvement.</p>
          <p>For individuals with a family history of affected family members, the prognosis is based on the degree of severity present in the family, as intrafamilial variability appears to be low.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with GCPS has clinical evidence of the disorder, the <italic toggle="yes">GLI3</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="gcps.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Cytogenetic testing.</bold> In pregnancies of a parent with a cytogenetically visible deletion of 7p13 or a balanced chromosome rearrangement, prenatal testing is possible by chromosome analysis of fetal cells obtained by chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation or by amniocentesis usually performed at approximately 15 to 18 weeks' gestation.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Molecular genetic testing.</bold> If the <italic toggle="yes">GLI3</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p><bold>Ultrasound examination.</bold> In pregnancies at 50% risk, prenatal ultrasound examination may detect polydactyly, macrocephaly, or other CNS abnormalities such as hydrocephalus. However, a normal ultrasound examination does not eliminate the possibility of GCPS in the fetus.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">GLI3</italic> pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="gcps.Resources">
        <title>Resources</title>
      </sec>
      <sec id="gcps.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="gcps.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Alterations that cause Greig cephalopolysyndactyly syndrome (GCPS) range from gross cytogenetic alterations to nucleic acid substitutions.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">GLI3</italic> is large, with exons spanning at least 296 kb of genomic DNA on the minus strand of chromosome 7, from 41,967,073 to 42,243,321 bp and comprising at least 15 exons in the current human genome build (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">genome.ucsc.edu</ext-link>; March 2006 build). The current reference sequence for the cDNA is an 8,228-nt sequence: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000168.5">NM_000168.5</ext-link>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="gcps" object-id="gcps.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> A number of putative benign variants exist in <italic toggle="yes">GLI3</italic> (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="gcps-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> [pdf]). Most of the variants have been seen in multiple unrelated persons and are not believed to be associated with any phenotypic effects, although they have not been rigorously analyzed for subtle effects. They are included in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="gcps-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> if they lie within an exon or if they are in an intron within 25 bp of an exon. Readers should refer to dbSNP to confirm these data and for additional data (SNPs are from Human Genome build 126).</p>
          <p><bold>Pathogenic allelic variants.</bold> A large variety of published pathogenic variants has been reported including cytogenetically visible translocations, interstitial deletions of 7p13, small insertions or deletions that cause frameshifts and premature truncation, nonsense variants, variants that alter a splice site, and missense variants that change an amino acid [<xref ref-type="bibr" rid="gcps.REF.wild.1997.1979">Wild et al 1997</xref>, <xref ref-type="bibr" rid="gcps.REF.kalffsuske.1999.1769">Kalff-Suske et al 1999</xref>, <xref ref-type="bibr" rid="gcps.REF.elson.2002.804">Elson et al 2002</xref>, <xref ref-type="bibr" rid="gcps.REF.debeer.2003.49">Debeer et al 2003</xref>, <xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al 2005</xref>]. (For more information, see <related-object source-id="gene" document-id="gcps" object-id="gcps.molgen.TA">Table A</related-object>.)</p>
          <p>Selected pathogenic variants reported in individuals with GCPS are listed in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="gcps-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf). Multiple new pathogenic variants have been identified by <xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al [2005]</xref>. See <xref ref-type="table" rid="gcps.T.selected_gli3_pathogenic_allelic">Table 4</xref>.</p>
          <table-wrap id="gcps.T.selected_gli3_pathogenic_allelic" position="anchor" orientation="portrait">
            <label>Table 4. </label>
            <caption>
              <p>Selected <italic toggle="yes">GLI3</italic> Pathogenic Allelic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.540_547del</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn181CysfsTer15<break/>(A181_T183delinsCfsTer15)</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_3" rowspan="20" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000168.5">NM_000168.5</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000159.3">NP_000159.3</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.658delC</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg220ValfsTer3</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.679+2_679+15del14del14</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.827-3C&#x0003e;G</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.868C&#x0003e;T</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg290Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1048dupT<break/>(1048_1049insT)</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr350LeufsTer62</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1074delC</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His358GlnfsTer7</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1497+1G&#x0003e;C</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1617_1633del</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg539SerfsTer7<break/>(R539_P545delinsSfsTer7)</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1789C&#x0003e;T</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln597Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1880_1881delAT</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His627ArgfsTer48</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2374C&#x0003e;T</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg792Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4119_4123delinsAGCCTGA<break/>(4119_4123delins7)</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro1374AlafsTer2<break/>(P1374_S1375delinsAfsTer2)</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4403dupT<break/>(4402_4403insT)</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu1469AlafsTer10</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4427delA</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn1476ThrfsTer12<break/>(S1477LfsTer11)</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4564delG</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala1522ProfsTer2</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4677dupC<break/>(4677_4678insC)</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1560ArgfsTer38</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1446C&#x0003e;G</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys482Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1874G&#x0003e;A</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg625Gln</td>
                </tr>
                <tr>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1873C&#x0003e;T</td>
                  <td headers="hd_h_gcps.T.selected_gli3_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg625Trp</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>
                  <xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al [2005]</xref>
                </p>
              </fn>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="gcps.TF.4.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The gene encodes a protein of 1,580 amino acids.</p>
          <p>Note: As the result of a cDNA sequencing error, older citations described a longer open reading frame that predicted a protein of 1,596 amino acids; the error was corrected in the GenBank entry NM_000168.3 and in subsequent versions of this sequence.</p>
          <p><italic toggle="yes">GLI3</italic> encodes a zinc finger transcription factor that is downstream of Sonic Hedgehog in SHH pathway (SHH-PTCH1-SMO-GLI1, GLI2, GLI3) [<xref ref-type="bibr" rid="gcps.REF.villavicencio.2000.1047">Villavicencio et al 2000</xref>]. The various GLI proteins in turn regulate genes further downstream in this pathway, including HNF3&#x003b2;, bone morphogenetic proteins, and other as-yet-unknown targets. The human gene is similar to the mouse paralog <italic toggle="yes">Gli3</italic> and the vertebrate <italic toggle="yes">GLI</italic> gene family is homologous to the <italic toggle="yes">Drosophila melanogaster</italic> gene cubitus interruptus (ci).</p>
          <p><bold>Abnormal gene product.</bold> The most common, if not sole, pathogenetic mechanism for GCPS is haploinsufficiency. Deletions that remove the entire gene cause a GCPS phenotype that is not known to be different from that caused by single nucleotide variants. In addition, mouse models support the hypothesis that haploinsufficiency is the mechanism. Although it is clear that haploinsufficiency of <italic toggle="yes">GLI3</italic> can cause GCPS, the pathogenic mechanism of 3' frameshift or nonsense variants and missense variants is not clear.</p>
          <p>It is important to note that mRNA or protein instability may be caused by some of these pathogenic variants in individuals with GCPS, a finding that would be entirely compatible with the general mechanism of haploinsufficiency.</p>
        </sec>
      </sec>
      <sec id="gcps.References">
        <title>References</title>
        <sec id="gcps.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="gcps.Literature_Cited.reflist0">
            <ref id="gcps.REF.allanson.2009.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allanson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunniff</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyme</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGaughran</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Elements of morphology: standard terminology for the head and face.</article-title>
                <source>Am J Med Genet A</source>
                <volume>149A</volume>
                <fpage>6</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">19125436</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.biesecker.2008.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The Greig cephalopolysyndactyly syndrome.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>3</volume>
                <fpage>10</fpage>
                <pub-id pub-id-type="pmid">18435847</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.biesecker.2009.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aase</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toriello</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Elements of morphology: standard terminology for the hands and feet.</article-title>
                <source>Am J Med Genet A</source>
                <volume>149A</volume>
                <fpage>93</fpage>
                <lpage>127</lpage>
                <pub-id pub-id-type="pmid">19125433</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.bilguvar.2007.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bilguvar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bydon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayrakli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercan-Sencicek</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayri</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiLuna</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seashore</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bronen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>State</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunel</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel syndrome of cerebral cavernous malformation and Greig cephalopolysyndactyly. Laboratory investigation.</article-title>
                <source>J Neurosurg</source>
                <volume>107</volume>
                <fpage>495</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18154020</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.debeer.2003.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Debeer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeters</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driess</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Smet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freese</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornholdt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzeschik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalff-Suske</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Variable phenotype in Greig cephalopolysyndactyly syndrome: Clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations.</article-title>
                <source>Am J Med Genet A</source>
                <volume>120A</volume>
                <fpage>49</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">12794692</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.elson.2002.804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perveen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>De novo GLI3 mutation in acrocallosal syndrome: broadening the phenotypic spectrum of GLI3 defects and overlap with murine models.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>804</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12414818</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.everman.2006">
              <mixed-citation publication-type="book">Everman DB. Hands and feet. In: Stevenson RE, Hall JG, eds. <italic toggle="yes">Human Malformations and Related Anomalies.</italic> 2 ed. New York: Oxford University Press; 2006:935-96</mixed-citation>
            </ref>
            <ref id="gcps.REF.gorlin.2001">
              <mixed-citation publication-type="book">Gorlin RJ, Cohen MM Jr, Hennekam RCM. Greig cephalopolysyndactyly syndrome. In: <italic toggle="yes">Syndromes of the Head and Neck</italic>. New York: Oxford University Press; 2001:995-6</mixed-citation>
            </ref>
            <ref id="gcps.REF.hall.2009.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Cassidy</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Elements of morphology: standard terminology for the periorbital region.</article-title>
                <source>Am J Med Genet A</source>
                <volume>149A</volume>
                <fpage>29</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">19125427</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.johnston.2007.e59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Facio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bick</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daentl</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meltzer</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>e59</fpage>
                <pub-id pub-id-type="pmid">17098889</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.johnston.2005.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivos-Glander</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killoran</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbott</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aughton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinulos</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flannery</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grange</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttmacher</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannibal</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henn</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyme</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppig</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macleod</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manchester</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcelis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzanti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendelsohn</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeschler</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moghaddam</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagon</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadler</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoler</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilstra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh Vockley</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zadeh</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>609</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15739154</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.johnston.2003.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivos-Glander</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aleck</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimke</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heilstedt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spence</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blancato</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>123A</volume>
                <fpage>236</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">14608643</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.kalffsuske.1999.1769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kalff-Suske</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wild</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornholdt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heuer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aalfs</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homfray</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;nig</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strenge</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzeschik</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>1769</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">10441342</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.kang.1997.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Olney</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>15</volume>
                <fpage>266</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9054938</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.koenig.2002.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woelki</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzeschik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Spectrum of the acrocallosal syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>108</volume>
                <fpage>7</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">11857542</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.kroisel.2001.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kroisel</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Phenotype of five patients with Greig syndrome and microdeletion of 7p13.</article-title>
                <source>Am J Med Genet</source>
                <volume>102</volume>
                <fpage>243</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11484201</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.putoux.2011.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Putoux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coene</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanay</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogur</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elkhartoufi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frison</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigonnot</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joy&#x000e9;</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruvost</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utine</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boduroglu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitschke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fertitta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akarsu</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bole-Feysot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cagnard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siffroi</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsanis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beales</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atti&#x000e9;-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <month>Jun</month>
                <volume>43</volume>
                <issue>6</issue>
                <fpage>601</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21552264</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.speksnijder.2013.1394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Speksnijder</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen-Overbeek</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knapen</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunshof</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogeboom</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ouwenland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolz</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessels</surname>
                    <given-names>MW</given-names>
                  </name>
                </person-group>
                <article-title>A de novo GLI3 mutation in a patient with acrocallosal syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>1394</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">23633388</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.villavicencio.2000.1047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Villavicencio</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walterhouse</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The sonic hedgehog-patched-gli pathway in human development and disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>67</volume>
                <fpage>1047</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11001584</pub-id>
              </element-citation>
            </ref>
            <ref id="gcps.REF.wild.1997.1979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wild</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalff-Suske</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vortkamp</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornholdt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;nig</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzeschik</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Point mutations in human GLI3 cause Greig syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1979</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">9302279</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="gcps.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="gcps.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genome.gov/page.cfm?pageID=10000356">Author's web page</ext-link>
          </p>
        </sec>
        <sec id="gcps.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>19 June 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 April 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 August 2006 (lgb) Revision: deletion/duplication analysis and prenatal diagnosis clinically available</p>
            </list-item>
            <list-item>
              <p>7 February 2006 (lgb) Revision: sequence analysis of <italic toggle="yes">GLI3</italic> clinically available</p>
            </list-item>
            <list-item>
              <p>20 September 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 October 2004 (cd) Revision: FISH-metaphase clinically available</p>
            </list-item>
            <list-item>
              <p>25 August 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 July 2001 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 February 2001 (lgb) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Greig Cephalopolysyndactyly Syndrome&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="gcps.F1" orientation="portrait">
          <label>Figure 1<break/><break/></label>
          <caption>
            <p>A. The mutational spectra of GCPS and PHS are distinct. GCPS is caused by pathogenic variants of all types, whereas PHS is only caused by truncating variants and one splice variant that generates a frameshift and a truncation. B. Within the frameshift variant category there is a correlation of the position of the truncation and the phenotype. GCPS is primarily caused by pathogenic variants 5' of nt 1998 and 3' of 3481, whereas PHS is exclusively caused by truncations between 1998 and 3481. Note that a single truncating variant in the PHS region can cause GCPS and has been observed in six apparently unrelated families.<xref ref-type="bibr" rid="gcps.REF.johnston.2005.609">Johnston et al [2005]</xref>, with permission</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gcps-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
